151 related articles for article (PubMed ID: 17284529)
41. Differences in the regulation of specific glycosylation in the pathogenesis of paroxysmal nocturnal hemoglobinuria and the Tn-syndrome.
Thurnher M; Fehr J; Berger EG
Exp Hematol; 1994 Mar; 22(3):267-71. PubMed ID: 7509289
[TBL] [Abstract][Full Text] [Related]
42. Molecular genetics of paroxysmal nocturnal hemoglobinuria.
Inoue N; Murakami Y; Kinoshita T
Int J Hematol; 2003 Feb; 77(2):107-12. PubMed ID: 12627844
[TBL] [Abstract][Full Text] [Related]
43. Deficient surface expression of glycosylphosphatidylinositol-anchored proteins in B cell lines established from patients with paroxysmal nocturnal hemoglobinuria.
Ueda E; Nishimura J; Kitani T; Nasu K; Kageyama T; Kim YU; Takeda J; Kinoshita T
Int Immunol; 1992 Nov; 4(11):1263-71. PubMed ID: 1282030
[TBL] [Abstract][Full Text] [Related]
44. Paroxysmal nocturnal hemoglobinuria: molecular pathogenesis and molecular therapeutic approaches.
Nishimura J; Smith CA; Phillips KL; Ware RE; Rosse WF
Hematopathol Mol Hematol; 1998; 11(3-4):119-46. PubMed ID: 9844822
[TBL] [Abstract][Full Text] [Related]
45. Glycosylphosphatidylinositol-anchored protein deficiency confers resistance to apoptosis in PNH.
Savage WJ; Barber JP; Mukhina GL; Hu R; Chen G; Matsui W; Thoburn C; Hess AD; Cheng L; Jones RJ; Brodsky RA
Exp Hematol; 2009 Jan; 37(1):42-51. PubMed ID: 19013003
[TBL] [Abstract][Full Text] [Related]
46. [Immunophenotyping study on the blood cells of the patients with paroxysmal nocturnal hemoglobinuria].
Chen G; Shao Z; Jia H; Chu Y; Shen D; Zhang Y; Zhang J
Zhonghua Xue Ye Xue Za Zhi; 1997 Apr; 18(4):190-2. PubMed ID: 15622765
[TBL] [Abstract][Full Text] [Related]
47. Affected paroxysmal nocturnal hemoglobinuria T lymphocytes harbor a common defect in assembly of N-acetyl-D-glucosamine inositol phospholipid corresponding to that in class A Thy-1- murine lymphoma mutants.
Armstrong C; Schubert J; Ueda E; Knez JJ; Gelperin D; Hirose S; Silber R; Hollan S; Schmidt RE; Medof ME
J Biol Chem; 1992 Dec; 267(35):25347-51. PubMed ID: 1460030
[TBL] [Abstract][Full Text] [Related]
48. Establishment of a human T-cell line with deficient surface expression of glycosylphosphatidylinositol (GPI)-anchored proteins from a patient with paroxysmal nocturnal haemoglobinuria.
Masuda T; Yonemura Y; Fujimoto K; Hidaka M; Nagakura S; Nakakuma H; Hata H; Sanada I; Kawakita M; Takatsuki K
Br J Haematol; 1994 May; 87(1):24-30. PubMed ID: 7524616
[TBL] [Abstract][Full Text] [Related]
49. [Clinical features and diagnosis of paroxysmal nocturnal hemoglobinuria: correlates with the deficiency of GPI-anchored membrane proteins].
Ninomiya H
Rinsho Ketsueki; 1994 Apr; 35(4):352-7. PubMed ID: 7518013
[TBL] [Abstract][Full Text] [Related]
50. Killer immunoglobulin-like receptors (KIR) and their HLA-ligands in Italian paroxysmal nocturnal haemoglobinuria (PNH) patients.
Cosentini E; Gargiulo L; Bruno P; Lastraioli S; Risitano A; Camerlingo R; Luongo V; Serra M; Sica M; Garzillo C; Giani U; Notaro R; Alfinito F; Ruggiero G; Terrazzano G
Tissue Antigens; 2012 Oct; 80(4):322-7. PubMed ID: 22803950
[TBL] [Abstract][Full Text] [Related]
51. Circulating PIG-A mutant T lymphocytes in healthy adults and patients with bone marrow failure syndromes.
Ware RE; Pickens CV; DeCastro CM; Howard TA
Exp Hematol; 2001 Dec; 29(12):1403-9. PubMed ID: 11750098
[TBL] [Abstract][Full Text] [Related]
52. Paroxysmal nocturnal hemoglobinuria: An acquired genetic disease.
Nishimura J; Murakami Y; Kinoshita T
Am J Hematol; 1999 Nov; 62(3):175-82. PubMed ID: 10539884
[TBL] [Abstract][Full Text] [Related]
53. In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing.
Risitano AM; Maciejewski JP; Green S; Plasilova M; Zeng W; Young NS
Lancet; 2004 Jul 24-30; 364(9431):355-64. PubMed ID: 15276395
[TBL] [Abstract][Full Text] [Related]
54. Minor populations of paroxysmal nocturnal hemoglobinuria-type cells in patients with chronic idiopathic neutropenia.
Damianaki A; Stagakis E; Mavroudi I; Spanoudakis M; Koutala H; Papadogiannis F; Kanellou P; Pontikoglou C; Papadaki HA
Eur J Haematol; 2016 Dec; 97(6):538-546. PubMed ID: 27124520
[TBL] [Abstract][Full Text] [Related]
55. The role of Wilms' tumor gene peptide-specific cytotoxic T lymphocytes in immunologic selection of a paroxysmal nocturnal hemoglobinuria clone.
Ikeda K; Shichishima T; Yasukawa M; Nakamura-Shichishima A; Noji H; Akutsu K; Osumi K; Maruyama Y
Exp Hematol; 2007 Apr; 35(4):618-26. PubMed ID: 17379072
[TBL] [Abstract][Full Text] [Related]
56. Possible pathogenic role of the transmembrane isoform of CD160 NK lymphocyte receptor in paroxysmal nocturnal hemoglobinuria.
Giustiniani J; Alaoui SS; Marie-Cardine A; Bernard J; Olive D; Bos C; Razafindratsita A; Petropoulou A; de Latour RP; Le Bouteiller P; Bagot M; Socié G; Bensussan A
Curr Mol Med; 2012 Feb; 12(2):188-98. PubMed ID: 22172098
[TBL] [Abstract][Full Text] [Related]
57. Thymoma followed by paroxysmal nocturnal hemoglobinuria: a unique clinical association in the context of multiorgan autoimmunity with a potential role for CD8+ T lymphocytes.
Palmieri G; Selleri C; Montella L; Bulgarelli G; Vitiello L; Merkabaoui G; Ricci P; Del Vecchio L; Masci A; Racioppi L; Rotoli B
Am J Hematol; 2006 Oct; 81(10):774-8. PubMed ID: 16838334
[TBL] [Abstract][Full Text] [Related]
58. Interleukin-2-dependent T-cell lines established from paroxysmal nocturnal hemoglobinuria patients.
Nakakuma H; Nagakura S; Horikawa K; Hidaka M; Kawaguchi T; Iwamoto N; Sanada I; Kagimoto T; Takatsuki K
Blood; 1994 Jul; 84(1):309-14. PubMed ID: 7517213
[TBL] [Abstract][Full Text] [Related]
59. Dynamics of hematopoiesis in paroxysmal nocturnal hemoglobinuria (PNH): no evidence for intrinsic growth advantage of PNH clones.
Araten DJ; Bessler M; McKenzie S; Castro-Malaspina H; Childs BH; Boulad F; Karadimitris A; Notaro R; Luzzatto L
Leukemia; 2002 Nov; 16(11):2243-8. PubMed ID: 12399968
[TBL] [Abstract][Full Text] [Related]
60. [Expression of three kinds of GPI-anchor proteins in paroxysmal nocturnal hemoglobinuria, aplastic anemia and myelodysplastic syndromes patients and their clinical implications].
Dong XY; Xu CG; Sun GR; Zhang T; Peng J
Zhonghua Xue Ye Xue Za Zhi; 2004 Apr; 25(4):198-201. PubMed ID: 15182554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
